No Data
No Data
Azenta Is Maintained at In-Line by Evercore ISI Group
Azenta Is Maintained at In-Line by Evercore ISI Group
Azenta Price Target Raised to $53.00/Share From $52.00 by Evercore ISI Group
Azenta Price Target Raised to $53.00/Share From $52.00 by Evercore ISI Group
Decoding 5 Analyst Evaluations For Azenta
Throughout the last three months, 5 analysts have evaluated Azenta (NASDAQ:AZTA), offering a diverse set of opinions from bullish to bearish.The following table provides a quick overview of their rece
Evercore Maintains Azenta(AZTA.US) With Hold Rating, Cuts Target Price to $53
Evercore analyst Vijay Kumar maintains $Azenta(AZTA.US)$ with a hold rating, and adjusts the target price from $55 to $53.According to TipRanks data, the analyst has a success rate of 47.4% and a tota
Azenta Insiders Sold US$1.6m Of Shares Suggesting Hesitancy
In the last year, many Azenta, Inc. (NASDAQ:AZTA) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When analyzing insider transactions, it is usually
Azenta Announces Collaboration With the Crohn's & Colitis Foundation to Support Its Crohn's Disease and Ulcerative Colitis Clinical Research
Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries BURLINGTON, Mass
No Data